Navegar por autor "Castro Iglesias, Angeles"

Acute hepatitis C in Spain. Retrospective study of 131 patients

2011- Castro Iglesias, Angeles; Morano Amado, Luis

Clinical experience of raltegravircontaining regimens in HIV-infected patients during rifampicin-containing treatment of tuberculosis

2011- Bello Rodríguez, Laura; Vázquez Rodríguez, Pilar; López Calvo, Soledad; Castro Iglesias, Angeles; Mena de Cea, Alvaro; [et al.]

Comparison of high ribavirin induction versus standard ribavirin dosing, plus peginterferon-alpha for the treatment of chronic hepatitis C in HIV-infected patients: the PERICO trial

2012- Mariño Callejo, Ana Isabel; Castro Iglesias, Angeles; Morano Amado, Luis; Corredoira Sánchez, Juan

Consenso Gallego Multidisciplinar sobre el Uso de Hipolipemiantes

2016- Botana López, Manuel Antonio; Aneiros Díaz, Angel Manuel; Bouza Piñeiro, Pablo; CAAMA?O ISORNA, CATALINA; Castro Iglesias, Angeles; [et al.]

DBP rs16846876 and rs12512631 polymorphisms are associated with progression to AIDS naive HIV-infected patients: a retrospective study

2019- Jimenez-Sousa, Maria Angeles; Jimenez, Jose Luis; Fernandez-Rodriguez, Amanda; Bellon, Jose Maria; Rodriguez, Carmen; [et al.]

Effectiveness, safety/tolerability of OBV/PTV/r +/- DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (CKD) stage IIIb-V and dialysis in Spanish clinical practice - Vie-KinD study

2019- Londono, Maria-Carlota; Riveiro-Barciela, Mar; Ahumada, Adriana; Munoz-Gomez, Raquel; Roget, Merce; [et al.]

Epidemiologia de la coinfeccion por VHC y VIH

2011- Castro Iglesias, Angeles

HCV genotype 3 and subtype 1b, but not 1a, are independent predictors of sustained virological response to pegIFN-RBV in HCV/HIVcoinfected patients with unfavourable IL28B variants

2011- Mariño Callejo, Ana Isabel; Castro Iglesias, Angeles

Hepatitis E 3ra Genotype Infection in People Living With HIV in Spain

2020- Rivero-Juarez, A; Frias, M; Lopez-Lopez, P; Berenguer, J; Garcia, F; [et al.]

High prevalence of subtype F in newly diagnosed HIV-1 persons in northwest Spain and evidence for impaired treatment response

2014- Pertega Diaz, Sonia; López Calvo, Soledad; Castro Iglesias, Angeles; Pedreira Andrade, José Domingo; Cañizares Castellanos, Angelina; [et al.]

HIV increases mean platelet volume during asymptomatic HIV infection in treatment-naive patients

2011- Bello Rodríguez, Laura; Castro Iglesias, Angeles; Mena de Cea, Alvaro; Baliñas Bueno, Josefa; Serrano Peña, Joaquin [et al.]

IMPACT OF HCV INFECTION IN A HIV COHORT FOLLOWED OVER 18 YEARS: PAST AND PRESENT

2015- Vázquez Rodríguez, Pilar; López Calvo, Soledad; Castro Iglesias, Angeles; Mena de Cea, Alvaro; Pedreira Andrade, José Domingo; [et al.]

Impact of HIV infection on sustained virological response to treatment against hepatitis C virus with pegylated interferon plus ribavirin

2015- Castro Iglesias, Angeles; Rubio Cid, Paula

Impact of Inosine Triphosphatase Gene Variants on the Risk of Anemia in HIV/Hepatitis C Virus-Coinfected Patients Treated for Chronic Hepatitis C

2011- Castro Iglesias, Angeles; Miralles Alvarez, María Celia; Ocampo Hermida, Antonio

Interim results on adherence to treatment of chronic C hepatitis monoinfected and HCV/HIV co-infected patients assessed by the adhepta questionnaire

2011- Castro Iglesias, Angeles; Tomé Martínez de Rituerto, Santiago

Late HIV Diagnosis but Earlier Antiretroviral Treatment Initiation in Northwest Spain: Impact of Current Treatment Guidelines

2019- Cid Silva, Purificación; Margusino Framinan, Luis; Balboa Barreiro, Vanesa; Pernas Souto, Berta; Mena de Cea, Alvaro; [et al.]

Late HIV Diagnosis but Earlier Antiretroviral Treatment Initiation in Northwest Spain: Impact of Current Treatment Guidelines.

2019- Cid Silva, Purificación; Margusino Framinan, Luis; Balboa Barreiro, Vanesa; Pernas Souto, Berta; Mena de Cea, Alvaro; [et al.]

Liver-related events and mortality among elderly patients with advanced chronic hepatitis C treated with direct-acting antivirals

2019- Rodríguez Osorio, Iria; Mena de Cea, Alvaro; Meijide Miguez, Hector M; Morano Amado, Luis; Delgado Blanco, Manuel; [et al.]

Lung cancer in patients living with HIV infection

2015- Castro Iglesias, Angeles; Pedreira Andrade, José Domingo; Marcos Rodríguez, Pedro Jorge; Poveda López, Eva; Rodríguez Osorio, Iria; [et al.]

Metabolic syndrome association with fibrosis development in chronic hepatitis B virus inactive carriers

2014- Vázquez Rodríguez, Pilar; Castro Iglesias, Angeles; Mena de Cea, Alvaro; Pedreira Andrade, José Domingo; Poveda López, Eva [et al.]

Repositorio digital RUNA

Navegar por autor "Castro Iglesias, Angeles"

Acute hepatitis C in Spain. Retrospective study of 131 patients ﻿

Clinical experience of raltegravircontaining regimens in HIV-infected patients during rifampicin-containing treatment of tuberculosis ﻿

Comparison of high ribavirin induction versus standard ribavirin dosing, plus peginterferon-alpha for the treatment of chronic hepatitis C in HIV-infected patients: the PERICO trial ﻿

Consenso Gallego Multidisciplinar sobre el Uso de Hipolipemiantes ﻿

DBP rs16846876 and rs12512631 polymorphisms are associated with progression to AIDS naive HIV-infected patients: a retrospective study ﻿

Effectiveness, safety/tolerability of OBV/PTV/r +/- DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (CKD) stage IIIb-V and dialysis in Spanish clinical practice - Vie-KinD study ﻿

Epidemiologia de la coinfeccion por VHC y VIH ﻿

HCV genotype 3 and subtype 1b, but not 1a, are independent predictors of sustained virological response to pegIFN-RBV in HCV/HIVcoinfected patients with unfavourable IL28B variants ﻿

Hepatitis E 3ra Genotype Infection in People Living With HIV in Spain ﻿

High prevalence of subtype F in newly diagnosed HIV-1 persons in northwest Spain and evidence for impaired treatment response ﻿

HIV increases mean platelet volume during asymptomatic HIV infection in treatment-naive patients ﻿

IMPACT OF HCV INFECTION IN A HIV COHORT FOLLOWED OVER 18 YEARS: PAST AND PRESENT ﻿

Impact of HIV infection on sustained virological response to treatment against hepatitis C virus with pegylated interferon plus ribavirin ﻿

Impact of Inosine Triphosphatase Gene Variants on the Risk of Anemia in HIV/Hepatitis C Virus-Coinfected Patients Treated for Chronic Hepatitis C ﻿

Interim results on adherence to treatment of chronic C hepatitis monoinfected and HCV/HIV co-infected patients assessed by the adhepta questionnaire ﻿

Late HIV Diagnosis but Earlier Antiretroviral Treatment Initiation in Northwest Spain: Impact of Current Treatment Guidelines ﻿

Late HIV Diagnosis but Earlier Antiretroviral Treatment Initiation in Northwest Spain: Impact of Current Treatment Guidelines. ﻿

Liver-related events and mortality among elderly patients with advanced chronic hepatitis C treated with direct-acting antivirals ﻿

Lung cancer in patients living with HIV infection ﻿

Metabolic syndrome association with fibrosis development in chronic hepatitis B virus inactive carriers ﻿

Acute hepatitis C in Spain. Retrospective study of 131 patients

Clinical experience of raltegravircontaining regimens in HIV-infected patients during rifampicin-containing treatment of tuberculosis

Comparison of high ribavirin induction versus standard ribavirin dosing, plus peginterferon-alpha for the treatment of chronic hepatitis C in HIV-infected patients: the PERICO trial

Consenso Gallego Multidisciplinar sobre el Uso de Hipolipemiantes

DBP rs16846876 and rs12512631 polymorphisms are associated with progression to AIDS naive HIV-infected patients: a retrospective study

Effectiveness, safety/tolerability of OBV/PTV/r +/- DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (CKD) stage IIIb-V and dialysis in Spanish clinical practice - Vie-KinD study

Epidemiologia de la coinfeccion por VHC y VIH

HCV genotype 3 and subtype 1b, but not 1a, are independent predictors of sustained virological response to pegIFN-RBV in HCV/HIVcoinfected patients with unfavourable IL28B variants

Hepatitis E 3ra Genotype Infection in People Living With HIV in Spain

High prevalence of subtype F in newly diagnosed HIV-1 persons in northwest Spain and evidence for impaired treatment response

HIV increases mean platelet volume during asymptomatic HIV infection in treatment-naive patients

IMPACT OF HCV INFECTION IN A HIV COHORT FOLLOWED OVER 18 YEARS: PAST AND PRESENT

Impact of HIV infection on sustained virological response to treatment against hepatitis C virus with pegylated interferon plus ribavirin

Impact of Inosine Triphosphatase Gene Variants on the Risk of Anemia in HIV/Hepatitis C Virus-Coinfected Patients Treated for Chronic Hepatitis C

Interim results on adherence to treatment of chronic C hepatitis monoinfected and HCV/HIV co-infected patients assessed by the adhepta questionnaire

Late HIV Diagnosis but Earlier Antiretroviral Treatment Initiation in Northwest Spain: Impact of Current Treatment Guidelines

Late HIV Diagnosis but Earlier Antiretroviral Treatment Initiation in Northwest Spain: Impact of Current Treatment Guidelines.

Liver-related events and mortality among elderly patients with advanced chronic hepatitis C treated with direct-acting antivirals

Lung cancer in patients living with HIV infection

Metabolic syndrome association with fibrosis development in chronic hepatitis B virus inactive carriers